Ms. Chen Xue | Chest infections | Best Researcher Award

Posted on by Infectious

Ms. Chen Xue | Chest infections | Best Researcher Award

Nanjing Medical University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Ms. Chen Xue graduated from Nanjing Medical University with a master’s degree in Medical Imaging and Nuclear Medicine. During her academic journey, she developed a strong foundation in advanced radiological techniques and diagnostic methodologies, setting the stage for her specialized career in medical imaging.

💼PROFESSIONAL ENDEAVORS

Ms. Chen serves in the Department of Radiology at Nanjing Brain Hospital, where she specializes in the diagnosis of central nervous system (CNS) and chest infection lesions. Her work combines clinical precision and innovation, addressing complex cases with an interdisciplinary approach that ensures accurate and effective patient care.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON DIAGNOSIS OF INFECTIOUS DISEASES

Ms. Chen’s research focuses on improving the diagnostic accuracy of infectious diseases, particularly those affecting the CNS and respiratory system. By integrating advanced imaging technologies with novel diagnostic protocols, she is making significant strides in early detection and management of these conditions.

🌍IMPACT AND INFLUENCE

Through her work, Ms. Chen has enhanced global medical practices, particularly in the domain of infection-related imaging. Her contributions to radiological diagnostics are influencing healthcare policies and inspiring collaborations among specialists across disciplines.

📚ACADEMIC CITES

Ms. Chen has authored and co-authored numerous SCI-indexed papers, which are frequently cited in leading scientific journals. These works focus on innovative diagnostic techniques and their application in infectious diseases, highlighting her expertise and thought leadership.

🏆RESEARCH GRANTS AND FUNDING

Ms. Chen has secured significant research grants to support her pioneering work in radiological imaging and its application to infectious disease diagnostics. These funds enable her to explore new technologies and methodologies that improve diagnostic precision.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Ms. Chen is dedicated to shaping the future of medical imaging. She envisions the integration of artificial intelligence (AI) and machine learning into radiological practices to enhance the speed and accuracy of infectious disease diagnosis. Her commitment to mentoring young radiologists ensures her enduring impact on the field.

🌟A VISIONARY IN INFECTIOUS DISEASES

Ms. Chen Xue is a visionary leader in the field of infectious disease diagnostics, merging clinical expertise with innovative research. Her work is paving the way for more effective diagnostic tools and personalized treatment options, addressing global healthcare challenges.

📑NOTABLE PUBLICATIONS 

“Chlamydia psittaci pneumonia – evolutionary aspects on chest CT”

Authors: Yang, N., Ou, Z., Sun, Q., Wu, J., Xue, C.
Publication Year: 2025
Journal: BMC Infectious Diseases

“MRI-Negative Temporal Lobe Epilepsy: A Study of Brain Structure in Adults Using Surface-Based Morphological Features”

Authors: He, Y., Huang, Y., Guo, Z., Xiao, C., Chai, X.
Publication Year: 2024
Journal: Journal of Integrative Neuroscience

“Directed Functional Connectivity Changes of Triple Networks for Stable and Progressive Mild Cognitive Impairment”

Authors: Zheng, D., Ruan, Y., Cao, X., Huang, Q., Xue, C.
Publication Year: 2024
Journal: Neuroscience

“Shared and Specific Changes of Cortico-Striatal Functional Connectivity in Stable Mild Cognitive Impairment and Progressive Mild Cognitive Impairment”

Authors: Ruan, Y., Zheng, D., Guo, W., Xue, C., Xiao, C.
Publication Year: 2024
Journal: Journal of Alzheimer’s Disease

“Progressing researches on brain structural magnetic resonance in the conversion from stable to progressive mild cognitive impairment | 轻度认知障碍稳定型向进展型转化的脑结构磁共振成像研究进展”

Authors: Zheng, D., Xue, C., Huang, Q.
Publication Year: 2024
Journal: Chinese Journal of Behavioral Medicine and Brain Science

Dr. Yuliang Liu | Animal Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Yuliang Liu | Animal Infectious Diseases | Best Researcher Award

China Animal Disease Control Center | China.

Author Profile

Scopus

🎓Education

Dr. Yuliang Liu, born on October 22, 1973, in Inner Mongolia, China, is a renowned professor at the China Animal Disease Control Center (CADC) since 2012. He holds a Ph.D. in Veterinary Science from Yangzhou University (2005), an M.Sc. in Veterinary Science from Guangxi University (2001), and a B.Sc. in Veterinary Medicine from Inner Mongolia Agricultural University (1998). His global experience includes postdoctoral research at the University of Pennsylvania (USA) and the Technical University of Denmark (DTU).

💼Professional Experience

Dr. Liu has over two decades of expertise in animal and zoonotic disease control, diagnostics, biosafety measures, and vaccine development. His work spans international collaborations and significant contributions to drafting Chinese standards for diagnosing animal diseases. He has supervised 17 students, including undergraduates and Ph.D. candidates, fostering future leaders in veterinary science.

🔬Technical Skills

Dr. Liu is skilled in molecular biology techniques, including reverse genetics, nucleic acid detection, and antimicrobial resistance research. His expertise in preparing Certified Reference Materials (CRMs) has led to the commercialization of five CRMs, enhancing diagnostic tools in veterinary medicine.

🔬Research Interests

A proponent of the One-Health approach, Dr. Liu focuses on animal disease surveillance, control, and vaccine innovation, emphasizing the intersection of animal and human health. His research extends to AMR studies and biosafety technologies.

📚Academic Contributions 

Dr. Liu is an editor for the journal Viruses and a member of professional societies like the American Society for Virology and the Chinese Veterinary Association. As a peer reviewer, he contributes to esteemed journals, including Viruses, Gene, and JAC-Antimicrobial Resistance.

🏆Awards & Recognition

  • Shen Nong China Agricultural Science and Technology Award (2017, 1st Prize)
  • Innovation Prize of DA BEI NONG Science and Technology Award (2015)
  • Named Outstanding Employee of CADC (2020–2022)

🎙️Teaching & Conferences

Dr. Liu has presented research globally, including at the World Organization for Animal Health (OIE) and the American Society for Virology. His mentorship has shaped the careers of many in the veterinary field.

Through his work, Dr. Liu continues to bridge scientific innovation and practical solutions for animal health worldwide.

📑Notable Publications 

“Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants”

Authors: He, L.; Wu, Q.; Zhang, Z.; Fan, R.; Li, Y.-P.
Year: 2024
Journal: Molecular Pharmaceutics, 21(8), pp. 3866–3879

“The proteomic analysis uncovers the cellular responses to the African swine fever virus membrane proteins p54, p17, and pB117L”

Authors: Chen, Y.; Ni, J.; Wang, C.; Wei, Y.; Liu, Y.
Year: 2024
Journal: Microbes and Infection, 26(5-6), Article 105348

“Establishment of a Triplex qPCR Assay for Differentiating Highly Virulent Genotype I Recombinant Virus from Low-Virulence Genotype I and Genotype II African Swine Fever Viruses Circulating in China”

Authors: Ding, L.; Ren, T.; Bing, G.; Sun, E.; Zhao, D.
Year: 2024
Journal: Transboundary and Emerging Diseases, Article ID 6206857

“Sequence characteristics and phylogenetic analysis of H9N2 subtype avian influenza A viruses detected from poultry and the environment in China, 2018”

Authors: Gao, X.; Wang, N.; Chen, Y.; Wang, C.; Liu, Y.
Year: 2021
Journal: PeerJ, 9, Article e12512

“An oligonucleotide-tagged microarray for routine diagnostics of colon cancer by genotyping KRAS mutations”

Authors: Liu, Y.; Gudnason, H.; Li, Y.-P.; Bang, D.D.; Wolf, A.
Year: 2014
Journal: International Journal of Oncology, 45(4), pp. 1556–1564

Assoc. Prof. Dr. Zhao Wang | Anti-HIV Drug | Best Researcher Award

Posted on by Infectious

Assoc. Prof. Dr. Zhao Wang | Anti-HIV Drug | Best Researcher Award

Shandong University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Dr. Zhao Wang embarked on his academic journey with a strong foundation in pharmaceutical sciences, earning his Bachelor’s degree in Biochemistry from Shandong University, where he graduated with honors. He pursued his Ph.D. in Pharmacology at the same institution, focusing on antiviral mechanisms, solidifying his expertise in infectious diseases and drug development.

💼PROFESSIONAL ENDEAVORS

As an Associate Professor at Shandong University, Dr. Wang has built an esteemed career specializing in the development and delivery of antiviral drugs. His leadership in the university’s Pharmaceutical Innovation Laboratory has fostered groundbreaking discoveries in drug design, particularly targeting infectious diseases like HIV.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANTI-HIV DRUG

Dr. Wang’s most notable contributions lie in the field of Anti-HIV Drug Candidate Development. He has pioneered research on novel drug delivery systems, ensuring targeted, efficient, and safe delivery of antiviral agents. His work has significantly enhanced therapeutic efficacy and reduced side effects, addressing critical challenges in HIV treatment.
Key advancements include:

  • Developing nanoparticle-based delivery systems for enhanced antiviral drug bioavailability.
  • Designing small-molecule inhibitors targeting HIV replication mechanisms.
  • Exploring combination therapies to prevent resistance and improve patient outcomes.

🌍IMPACT AND INFLUENCE

Dr. Wang’s research has had a transformative impact on global health, particularly in low-resource settings where accessible and effective HIV treatments are paramount. His contributions have influenced international guidelines on antiviral drug administration and inspired collaborations with leading research institutions worldwide.

📚ACADEMIC CITATIONS

Dr. Wang’s work has garnered extensive recognition, with over 1,200 citations across peer-reviewed journals such as Antiviral Research and Journal of Medicinal Chemistry. His seminal papers on antiviral drug design are considered benchmarks in the field of HIV therapeutics.

🏆RESEARCH GRANTS AND FUNDING

Dr. Wang has secured substantial funding from prestigious organizations, including:

  • National Natural Science Foundation of China (NSFC)
  • World Health Organization (WHO)
  • Collaborative grants with pharmaceutical giants like Gilead Sciences

These funds have propelled his lab to the forefront of antiviral research.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Wang’s commitment to advancing antiviral drug development extends beyond the lab. He actively mentors young researchers, fostering the next generation of scientists. His vision includes the integration of AI and machine learning to accelerate drug discovery processes, paving the way for even more effective treatments for HIV and other infectious diseases.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Zhao Wang is a trailblazer whose work exemplifies excellence in combating infectious diseases. His contributions to anti-HIV drug development have not only shaped the trajectory of antiviral therapy but also offered hope to millions affected by HIV worldwide.

📑NOTABLE PUBLICATIONS 

“Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP”

Authors: Zhou, Z., Sun, Y., Qin, Y., … Kang, D., Liu, X.
Year: 2024
Journal: European Journal of Medicinal Chemistry

“Assessing the impact of long-term storage on the quality and integrity of biological specimens in a reproductive biobank”

Authors: Wang, Z., Zhang, C., Zhang, X., Bian, Y., Cao, Y.
Year: 2024
Journal: Bioengineering and Translational Medicine

“Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Design, Synthesis, and Biological Evaluation”

Authors: Zhuo, Z., Wang, Z., Jing, L., … Liu, X., Kang, D.
Year: 2024
Journal: International Journal of Molecular Sciences

“Structure-based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug-like profiles”

Authors: Wang, Z., Wang, W., Gao, Z., … Zhan, P., Liu, X.
Year: 2024
Journal: Journal of Medical Virology

“Design and synthesis of Fsp3-enriched spirocyclic-substituted diarylpyrimidine derivatives as novel HIV-1 NNRTIs”

Authors: Sang, Z., Zhang, T., Wang, Z., … Zhan, P., Liu, X.
Year: 2024
Journal: Chemical Biology and Drug Design

Ms. Xiu Chen | HIV Treatment | Best Researcher Award

Posted on by Infectious

Ms. Xiu Chen | HIV Treatment | Best Researcher Award

Guangxi medical university, China.

Professional Profiles

Scopus Profile

🎓Education

Dr. Xiu Chen earned her Ph.D. in Epidemiology and Medical Statistics from Guangxi Medical University. Her academic training has equipped her with a solid foundation in statistical methods, epidemiological principles, and molecular research techniques, making her a valuable contributor to HIV/AIDS research.

 

💼Experience

With a focus on innovation, Dr. Chen has published eight high-impact articles in respected journals, including Emerging Microbes & Infections and Journal of Medical Virology. In addition, she has been granted a patent for her work on HIV/AIDS therapeutic strategies, showcasing her ability to translate research into practical applications.

 

🔍Research Interest

Dr. Chen’s primary research interest lies in identifying therapeutic targets for HIV/AIDS. Her work highlights the role of LncRNA LINC02453 in inhibiting HIV-1 replication, providing new insights into the virus’s resistance mechanisms. This focus underscores her dedication to developing innovative treatments to combat HIV/AIDS.

 

👩‍🏫Technical Skills

Dr. Chen possesses expertise in identifying biomarkers, molecular characterization of HIV-1, and analyzing epidemiological data. Her technical skills enable her to uncover novel therapeutic targets and address critical challenges in combating HIV/AIDS.

 

📚Academic Citations 

Dr. Chen’s research has been featured in leading scientific journals, emphasizing her contributions to the field of HIV research. Her studies on molecular mechanisms and biomarkers have gained recognition in journals such as Frontiers in Immunology and BMC Public Health, reflecting her impact in advancing knowledge in HIV epidemiology and treatment.

📑Top Note Publications

Long Noncoding RNA LINC02453 Inhibits HIV-1 Replication by Binding With SEC13 to Regulate the Viral Productive Cycle

Authors: Chen, X., Chen, R., Wen, L., Liang, H., Jiang, J.
2024
Journal: Journal of Medical Virology

Application of ‘CDC-Public Security Bureau-NGO’ Joint Prevention and Control Mechanism Allied AIDS Prevention and Control in Guigang, Guangxi

Authors: Tao, X., Huang, Y., Zheng, P., Wei, F., Jiang, J.
2024
Journal: BMC Public Health

A Bibliometric Analysis of m6A Methylation in Viral Infection from 2000 to 2022

Authors: Tao, X., Wang, G., Wei, W., Ye, L., Jiang, J.
2024
Journal: Virology Journal

 Immunogenicity of an Inactivated COVID-19 Vaccine in People Living with HIV in Guangxi, China: A Prospective Cohort Study

Authors: Wu, Y., Wang, X., Huang, Y., Liang, H., Jiang, J.
Year: 2024
Journal: Viruses

Spectrum and Mortality of Opportunistic Infections Among HIV/AIDS Patients in Southwestern China

Authors: Meng, S., Tang, Q., Xie, Z., Zhou, B., Lin, J.
2023
Journal: European Journal of Clinical Microbiology and Infectious Diseases

Prof. Hongbo Wu | Reproductive Medicine | Best Researcher Award

Posted on by Infectious

Prof. Hongbo Wu | Reproductive Medicine | Best Researcher Award

Qinzhou Maternity and Child Health Hospital | China.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Wu Hongbo earned his doctorate from the prestigious Xiangya School of Medicine, Central South University, laying a robust foundation for his illustrious career in reproductive medicine. His academic training provided a unique blend of clinical expertise and a deep understanding of scientific inquiry, setting the stage for his future endeavors.

💼PROFESSIONAL ENDEAVORS

Dr. Wu began his career at the Reproductive Medical Research Center, The First Affiliated Hospital of Guangxi Medical University, where he contributed to cutting-edge clinical and scientific advancements in assisted reproductive technology (ART) from 2004 to 2019. Since April 2019, he has served as the Director of the Reproductive Medicine Center at Qinzhou Maternity and Child Health Hospital, where he continues to push the boundaries of ART to transform the lives of his patients.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON REPRODUCTIVE MEDICINE

Dr. Wu specializes in managing complex reproductive conditions, including advanced maternal age, decreased ovarian reserve, recurrent IVF failure, and recurrent miscarriage. His research emphasizes innovative treatments such as platelet-rich plasma therapy, growth hormone applications, and novel interventions for thin endometrium and diminished ovarian reserve.
Key studies include:

  • Warm Acupuncture and Platelet-Rich Plasma Therapy for endometrial improvement.
  • The role of GnRH agonists and growth hormones in enhancing implantation success rates.
  • Pioneering work on mRNA modifications in ovarian follicle development and their implications for reproductive success.

🌍IMPACT AND INFLUENCE

Dr. Wu’s leadership extends beyond clinical practice. As a member of several influential committees, including the Guangxi Human Assisted Reproductive Technology Management Committee and the Reproductive Medicine Professional Committee of the Guangxi Medical Association, he has significantly shaped reproductive health policies and practices in Guangxi and beyond.

📚ACADEMIC CITATIONS

His research has been recognized in numerous high-impact academic journals, including:

  • Journal of Nanobiotechnology
  • Microbial Cell Factories
  • MicrobiologyOpen
  • Journal of Clinical Laboratory Analysis
  • Chemical Engineering Journal
  • Talanta These publications underscore his contributions to the field of microbiology, particularly in diagnostic technologies and resistance mechanisms.

🏆RESEARCH GRANTS AND FUNDING

Dr. Wu has led and participated in multiple provincial and departmental research projects, securing funding for studies on innovative therapies like stem cell transplantation and telemedicine in ART. These projects underscore his commitment to improving outcomes for patients facing complex reproductive challenges.

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a visionary in reproductive medicine, Dr. Wu continues to advance the field through his clinical expertise, innovative research, and leadership. His focus on integrating technology, such as telemedicine systems, into ART practices exemplifies his forward-thinking approach. Dr. Wu’s work has the potential to redefine reproductive healthcare, ensuring accessibility and improved outcomes for future generations.

📑NOTABLE PUBLICATIONS

“PCBP1/2 and TDP43 Function as NAT10 Adaptors to Mediate mRNA ac4C Formation in Mammalian Cells”

Authors: Jiang, Z.-Y.; Wu, Y.-K.; Deng, Z.-Q.; Wu, H.-B.; Fan, H.-Y.
Year: 2024
Journal: Advanced Science

“SARS-CoV-2 infection negatively impacts on the quality of embryos by delaying early embryonic development”

Authors: Ma, L.; Yao, Y.; Zhang, Z.; Liu, Z.; Ma, Y..
Year: 2024
Journal: American Journal of Reproductive Immunology

“NAT10-mediated mRNA N4-acetylcytidine modifications in mouse oocytes constitute a checkpoint of ovarian follicle development”

Authors: Wang, W.-J.; Wu, Y.-K.; Liu, S.-Y.; Wu, H.-B.; Fan, H.-Y.
Year: 2024
Journal: Science Bulletin

“Administration of depot GnRH agonist prior to programmed frozen-thawed embryo transfer does not improve the live birth rate in ovulatory women: A large, multi-center retrospective study”

Authors: Wu, H.; Wei, F.; Tan, W.; Song, G.; Liu, L.
Year: 2022
Journal: Medicine (United States)

“The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis”

Authors: Yuan, L.; Wu, H.; Huang, W.; Qin, A.; Yang, Y.
Year: 2021
Journal: Reproductive Biology and Endocrinology

Prof. Leisheng Zhang | Stem Cells | Best Researcher Award

Posted on by Infectious

Prof. Leisheng Zhang | Stem Cells | Best Researcher Award

Shandong Second Medical University | China.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Professor Leisheng Zhang’s academic journey began with a Bachelor’s degree in Veterinary Medicine from Jilin University (2007-2012). He then pursued a Doctor of Philosophy (Ph.D.) in Cell Biology at Peking Union Medical College & Chinese Academy of Medical Sciences, where he specialized in hematology and blood diseases (2012-2018). This foundation in cellular biology was further strengthened through postdoctoral research at Nankai University (2018-2020), focusing on cell biology, and later at the Chinese Academy of Sciences, Hefei Institute of Physical Science (2021-2023) in biophysics, cementing his expertise in stem cell biology and advanced technologies.

💼PROFESSIONAL ENDEAVORS

Professor Zhang has held several key academic and clinical positions:

  • Associate Professor at Nankai University (2020-2021) and Shandong First Medical University (2021-2023).
  • Professor at the NHC Key Laboratory of Diagnosis and Therapy of Gastrointestinal Tumors (2021-present), where his research intersects with clinical applications in cancer therapy.
  • Since 2023, he has been serving as a Professor at The Fourth People’s Hospital of Jinan, furthering his influence in the realm of medical research and patient care.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON STEM CELLS

Professor Zhang’s research is centered around mesenchymal stem/stromal cells (MSCs), focusing on their early development from human pluripotent stem cells (hPSCs), their cellular phenotype, and genomic analysis. Notably, his work has identified key master regulators (e.g., TWIST1, MSX2, PRAME) in MSC development. Using a small molecule library-based cell programming strategy, he has developed methods for generating specific MSC subpopulations from hPSCs and peripartum tissues. His research aims to decode the molecular mechanisms and functional properties of MSCs through high-throughput sequencing technologies, including RNA-SEQ, WGS, and single-cell RNA-SEQ, revealing a multifaceted understanding of MSC biology in both healthy donors and clinical patients.

🌍IMPACT AND INFLUENCE

Professor Zhang’s work has had a profound impact in stem cell biology and immunotherapy, particularly with his innovative approaches to natural killer (NK) cells. His development of a “3ILs”-based strategy for high-efficiency NK cell generation from various origins (e.g., peripheral blood, umbilical cord blood, bone marrow) has opened new avenues for immunotherapy. His research on hematopoietic stem/progenitor cells (HSPCs) and CAR-T therapies shows his visionary approach in cell-based therapies and cancer immunotherapy, with potential clinical applications in personalized medicine.

📚ACADEMIC CITATIONS

Professor Zhang has authored over 50 scientific articles, with 44 SCI-indexed papers, contributing to top journals such as Cell Research (2015), Journal of Hematology & Oncology (2017), and Stem Cell Reports (2018-2023). His work is frequently cited, reflecting the significant impact he has made in stem cell research, tumor immunology, and immune cell therapies. Additionally, his expertise has resulted in 17 books on topics ranging from stem cells to infectious diseases and tumor immunology, alongside over 30 national patents in China.

🏆RESEARCH GRANTS AND FUNDING

Zhou’s work has attracted funding and grants from various research bodies and academic institutions, allowing him to explore innovative technologies in microbial diagnostics and resistance. His research aligns with global priorities in infectious disease control and antimicrobial stewardship, making him a prominent figure in this domain.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Professor Zhang’s legacy lies in his transformative contributions to stem cell biology, immunology, and regenerative medicine. His research has not only advanced our understanding of MSC development and immune cell function but also laid the foundation for future breakthroughs in personalized cancer therapies and immune cell-based treatments. His work on hPSCs differentiation towards hematopoietic stem cells (HSPCs) and the development of iPSC-CAR-T cells will likely continue to shape the future of clinical applications in immunotherapy and cell-based treatments.

🌟A VISIONARY IN INFECTIOUS DISEASES

While Professor Zhang’s primary focus is on stem cells and immunotherapy, his work on immune cells such as NK cells is highly relevant to infectious diseases. By studying NK cell biology and leveraging technologies like scRNA-SEQ and Raman spectroscopy, he is contributing to the development of immune cell therapies that could offer innovative solutions for treating infectious diseases as well as cancer. His interdisciplinary approach positions him as a visionary in both infectious disease research and cell-based immunotherapy.

📑NOTABLE PUBLICATIONS 

“Proteomics analysis revealed the therapeutic role of Adipose-derived Mesenchymal Stem Cells on Radiation-Induced Colorectal Fibrosis in rats”

  • Authors: Leisheng Zhang
  • Publication Year: 2024
  • Journal: Biomedicine & Pharmacotherapy

“VCAM-1+ Mesenchymal Stem/Stromal Cells Reveal Preferable Efficacy Upon an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Over the VCAM-1− Counterpart”

  • Authors: Leisheng Zhang
  • Publication Year: 2024
  • Journal: Neurochemical Research

“Progress of Clinical Research on Perinatal Stem Cells”

  • Authors: Leisheng Zhang
  • Publication Year: 2024
  • Journal: Chinese Journal of Cell and Stem Cell (Electronic Edition)

“The Application and Efficacy of Voice Therapy and Closed Reduction Under Local Anesthesia Combination for Arytenoid Dislocation”

  • Authors: Leisheng Zhang
  • Publication Year: 2024
  • Journal: Journal of Voice

“Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer”

  • Authors: Leisheng Zhang
  • Publication Year: 2024
  • Journal: JAMA Oncology

Dr. Yusun Zhou | Antimicrobial | Best Researcher Award

Posted on by Infectious

Dr. Yusun Zhou | Antimicrobial | Best Researcher Award

The Affiliated Hospital of Qingdao University | China.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Yusun Zhou completed his M.D. at Huazhong University of Science and Technology in 2015, providing him with a strong foundation in medicine. His academic journey was marked by a deep interest in clinical microbiology, which led him to pursue further research in microbial diagnostics.

💼PROFESSIONAL ENDEAVORS

After graduating, Zhou began his career at the Affiliated Hospital of Qingdao University, where he gained hands-on experience in clinical practice. Currently, he works at the Department of Clinical Microbiology Laboratory, applying his expertise to advance rapid microbial identification and resistance detection.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANTIMICROBIAL

Zhou is committed to the development and application of rapid detection techniques for microbial identification and antimicrobial resistance. His work has focused on innovating new diagnostic methods that are both efficient and cost-effective, crucial in the fight against the growing threat of antimicrobial resistance (AMR).

🌍IMPACT AND INFLUENCE

Zhou’s research has made a significant impact on clinical microbiology, contributing to the global effort to combat antimicrobial resistance. His studies have the potential to transform healthcare systems by enabling faster diagnoses and more targeted treatments, improving patient outcomes and enhancing public health globally.

📚ACADEMIC CITATIONS

His research has been recognized in numerous high-impact academic journals, including:

  • Journal of Nanobiotechnology
  • Microbial Cell Factories
  • MicrobiologyOpen
  • Journal of Clinical Laboratory Analysis
  • Chemical Engineering Journal
  • Talanta These publications underscore his contributions to the field of microbiology, particularly in diagnostic technologies and resistance mechanisms.

🏆RESEARCH GRANTS AND FUNDING

Zhou’s work has attracted funding and grants from various research bodies and academic institutions, allowing him to explore innovative technologies in microbial diagnostics and resistance. His research aligns with global priorities in infectious disease control and antimicrobial stewardship, making him a prominent figure in this domain.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Looking forward, Zhou is poised to leave a lasting legacy in the field of clinical microbiology. His research on rapid diagnostic techniques and antimicrobial resistance is paving the way for breakthroughs in both basic science and clinical applications. In the future, he will likely play a key role in shaping global health policy and healthcare practices related to infectious diseases and resistance management.

🌟A VISIONARY IN INFECTIOUS DISEASES

Zhou is a visionary in the realm of infectious diseases, particularly in the context of antimicrobial resistance. His innovative approach to rapid diagnostics reflects his commitment to tackling one of the most pressing challenges in modern medicine. By merging cutting-edge technology with clinical expertise, Zhou is laying the groundwork for future solutions to combat the growing crisis of drug-resistant infections.

📑NOTABLE PUBLICATIONS 

“A Magnetic Epitope-Imprinted Microsphere Used for Selective Separation and Rapid Detection of SHV-type β-lactamases in Bacteria: A Novel Strategy of Antimicrobial Resistance Detection”

Authors: Zhou, Y., Wang, K., Li, L., Wang, Q., Yu, B.
Year: 2024
Journal: Journal of Nanobiotechnology

“A Magnetic Molecularly Imprinted Electrochemical Sensor with Selective and Sensitive Detection Ability Towards Methotrexate in Serum Samples”

Authors: Sun, S., Li, S., Sun, Z., Tian, Q., Zhou, T.
Year: 2024
Journal: Journal of the Electrochemical Society

“Expression and Purification of Soluble Recombinant β-lactamases Using Escherichia coli as Expression Host and pET-28a as Cloning Vector”

Authors: Li, L., Li, H., Tian, Q., Zhu, Y., Zhou, Y.
Year: 2022
Journal: Microbial Cell Factories

“Magnetic Molecularly Imprinted Polymers for the Rapid and Selective Extraction and Detection of Methotrexate in Serum by HPLC-UV Analysis”

Authors: Zhou, T., Deng, Z., Wang, Q., Tian, Q., Lun, L.
Year: 2022
Journal: Molecules

“A Rapid and Highly Effective Approach for SARS-CoV-2 Nucleic Acid Daily Testing in More Than Four Thousand Single-Tube Samples”

Authors: Zhou, Y., Han, C., Li, H., Xuan, C., Tian, Q.
Year: 2022
Journal: Journal of Clinical Laboratory Analysis

Prof. Dr. Wei Zhang | Antibiotic | Best Researcher Award

Posted on by Infectious

Prof. Dr. Wei Zhang | Antibiotic | Best Researcher Award

Shandong University | China.

Author Profile

Orcid ID
🎓EARLY ACADEMIC PURSUITS

Wei Zhang, Ph.D., started his academic journey in bioengineering with a B.En. from Liaocheng University, China, in 2005. His passion for scientific inquiry led him to Xiamen University, where he pursued his M.S. (2005-2007) and Ph.D. (2007-2012) under the mentorship of Professors Yaojian Huang and Yuemao Shen. During this period, Dr. Zhang’s early research laid the foundation for his future work in bioengineering, focusing on molecular and cellular processes.

💼PROFESSIONAL ENDEAVORS

  • 2012: After completing his doctoral studies, Dr. Zhang began his academic career as an Assistant Professor at the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), Chinese Academy of Sciences.
  • 2014: He was promoted to Associate Professor at QIBEBT, where he expanded his research on bioengineering, particularly in antibiotics and bioenergy.
  • 2016-2017: Dr. Zhang took a postdoctoral position in Vanderbilt University, working under the guidance of Professor F. P. Guengerich, gaining expertise in the biochemical mechanisms involved in drug metabolism and infectious diseases.
  • 2018: He was recruited as a Full Professor at Shandong University, continuing his groundbreaking work in antibiotics and infectious disease research.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANTIBIOTICS

Dr. Zhang’s work has significantly contributed to the understanding and development of antibiotics and their mechanisms of action. His research delves into:

  • Antibiotic resistance mechanisms: Understanding how bacteria evolve resistance to current antibiotics.
  • Bioengineering solutions: Using biotechnology to design new antimicrobial agents that can bypass common resistance pathways.
  • Antibiotic biosynthesis: Studying natural microbial antibiotics for innovative treatments. His research is particularly relevant in the context of the global antibiotic resistance crisis, which has spurred him to focus on novel antimicrobial strategies.

🌍IMPACT AND INFLUENCE

Dr. Zhang’s academic influence spans both China and international scientific communities:

  • His collaborations with international labs (e.g., University of Nebraska-Lincoln and Vanderbilt University) have expanded his global network.
  • He has published extensively in high-impact journals, contributing significantly to the field of bioengineering and antibiotic research.
  • Dr. Zhang’s research on drug metabolism and bacterial resistance has the potential to reshape the future of infectious disease treatment, influencing policies, drug design, and healthcare practices worldwide.

📚ACADEMIC CITATIONS

Dr. Zhang has authored numerous scientific papers that have garnered widespread citation within the field of bioengineering and antibiotics. His work has been referenced by both academics and industry leaders, positioning him as a thought leader in bioengineering and antimicrobial research.

🏆RESEARCH GRANTS AND FUNDING

Dr. Zhang has received substantial research funding from national and international sources, including:

  • China Scholarship Council: Supported his joint Ph.D. studies in the USA.
  • Multiple grants for antibiotic research, biotechnology innovations, and infectious disease solutions. These resources have enabled his lab to explore innovative research on antibiotic resistance, bioenergy, and microbial genomics.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Zhang’s contributions are paving the way for future innovations in combating antibiotic-resistant bacteria and exploring novel bioengineering solutions:

  • His work in biosynthesis and bioengineering will likely lead to next-generation antibiotics.
  • Future research initiatives are focused on integrating artificial intelligence with antibiotic development, ensuring that new, sustainable treatments emerge in a rapidly changing microbiome.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Zhang’s visionary approach lies in leveraging biotechnology, bioengineering, and molecular biology to develop the next frontier of antimicrobials. As a scientific leader, he emphasizes:

  • Collaborative research to bridge the gap between academia and industry.
  • Sustainable solutions for global health challenges, particularly in the area of antibiotic resistance.

📑NOTABLE PUBLICATIONS 

“Engineering Bafilomycin High-Producers by Manipulating Regulatory and Biosynthetic Genes in the Marine Bacterium Streptomyces lohii”

Authors: Wei Zhang
Publication Year: 2021
Journal: Marine Drugs

“Structural Basis for Selective Oxidation of Phosphorylated Ethylphenols by Cytochrome P450 Monooxygenase CreJ”

Authors: Wei Zhang
Publication Year: 2021
Journal: Applied and Environmental Microbiolog

“Structural Basis for Substrate Specificity of the Peroxisomal Acyl-CoA Hydrolase MpaH’ Involved in Mycophenolic Acid Biosynthesis”

Authors: Wei Zhang
Publication Year: 2021
Journal: FEBS Journa

“Engineering Cytochrome P450 Enzyme Systems for Biomedical and Biotechnological Application”

Authors: Wei Zhang
Publication Year: 2020
Journal: Journal of Biological Chemistr

“Fungal-Derived Brevianamide Assembly by a Stereoselective Semipinacolase”

Authors: Wei Zhang
Publication Year: 2020
Journal: Nature Catalysis

Prof. Fangfang Chen | Nanomedicine | Best Researcher Award

Posted on by Infectious

Prof. Fangfang Chen | Nanomedicine | Best Researcher Award

Jilin university | China.

Author Profile

Scopus
Orcid ID
🎓EARLY ACADEMIC PURSUITS

Dr. Fang-Fang Chen embarked on her academic journey with a Ph.D. in Immunology from the Norman Bethune College of Medicine of Jilin University in 2010, where her thesis focused on Leukemia Cell Apoptosis-Related Genes. She also earned a Master’s degree in Immunology in 2007, studying Human Follistatin and MUC1 histological expressions. In 2002, she completed her M.D. in Clinical Medicine from the same prestigious institution.

💼PROFESSIONAL ENDEAVORS

Dr. Chen has held various influential academic positions:

  • Professor at the Nanomedical Translational Research Center, China-Japan Union Hospital of Jilin University since 2018, where she focuses on nanomedicine.
  • She also serves as a Professor in the Laboratory of Gastrointestinal Colorectal and Anal Surgery since 2017.
  • Previously, she was a Postdoctoral Fellow in the Department of Nanomedicine, Colorado University (2014-2016).
  • Her clinical career includes roles as a Physician in Neurology at the Sixth Hospital of Guangzhou (2002-2005).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON NANOMEDICINE

Dr. Chen is recognized for her work in nanomedicine, particularly focusing on nanoworm-based targeted therapies for leukemia and cancer immunotherapy. Her research on superparamagnetic iron oxide nanoworms (SPIO) conjugated with monoclonal antibodies has shown promise in targeted therapies for acute myeloid leukemia and B-lymphoblastic leukemia. Her groundbreaking work in DNA sequencing techniques also extends to the exploration of immune mechanisms in cancer and leukemia therapies.

🌍IMPACT AND INFLUENCE

Dr. Chen’s work has a significant impact on both nanomedicine and cancer immunotherapy, particularly in leukemia treatment. She has shaped the landscape of targeted cancer therapies through her innovative research on nanotechnology in the field of oncology. Her contributions to immunology and nanomedicine have earned her recognition and awards, including the 17th China Young Women Scientist Award in 2022 and multiple accolades for her leadership in scientific advancements.

📚ACADEMIC CITATIONS

Dr. Chen’s research has been widely cited, particularly for her contributions to nanomedicine and cancer immunotherapy. Her projects, including the superparamagnetic iron oxide nanoworm studies, are frequently referenced in scientific literature, demonstrating her influence in the field of cancer biology and targeted therapies. Her work continues to provide new insights into the immune mechanisms involved in leukemia.

🏆RESEARCH GRANTS AND FUNDING

Dr. Chen has secured multiple prestigious research grants, reflecting her leadership in advancing nanomedicine and cancer therapy:

  • National Natural Science Foundation of China: For projects on Feumoxytol in leukemia therapy (2023-2026) and superparamagnetic iron oxide nanoworms in leukemia treatment (2018-2020).
  • Jilin University: Seed funding for distinguished young scholars in nanomedicine (2017) and several other major grants in cancer research.
  • Her research projects are supported by various national and provincial foundations, allowing her to explore targeted immunotherapy, leukemia, and cancer biomarkers.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Chen’s career is not just about research but also about education and mentorship. As a professor, she is shaping the next generation of scientists in nanomedicine and cancer therapy. Her legacy is cemented in her ongoing contributions to medical research, particularly in the development of novel cancer therapies and personalized medicine. Her future contributions are poised to further transform the medical landscape, especially in oncology and immunology.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Fang-Fang Chen is a visionary in the field of infectious diseases and cancer immunotherapy, focusing on nanotechnology-based treatments. Her work in immune mechanisms and DNA sequencing is helping pave the way for more effective targeted therapies and personalized treatments for a range of diseases, including leukemia.

📑NOTABLE PUBLICATIONS 

“Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity”

Authors: Li, Y., Wu, W., Liu, Q., Gao, M., Chen, F.
Publication Year: 2024
Journal: Nature Communications
Citations: 0

“Atomic Interface Engineering-Mediated Metallene Nanozyme Boosts Efficient Photothermal Catalytic Tumor-Specific Therapy”

Authors: Wu, J., Jiao, D., Liu, Q., Cui, X., Chen, F.
Publication Year: 2024
Journal: Advanced Functional Materials
Citations: 2

“Emerging Roles of Graphitic Carbon Nitride-based Materials in Biomedical Applications”

Authors: Zhang, Y., Sun, S., Wu, Y., Chen, F.
Publication Year: 2024
Journal: ACS Biomaterials Science and Engineering
Citations: 1

“Tensile Strain-Mediated Bimetallene Nanozyme for Enhanced Photothermal Tumor Catalytic Therapy”

Authors: Wu, J., Liu, Q., Jiao, D., Cui, X., Chen, F.
Publication Year: 2024
Journal: Angewandte Chemie – International Edition
Citations: 8

“A biomimetic ion channel shortens the QT interval of type 2 long QT syndrome through efficient transmembrane transport of potassium ions”

Authors: Sun, S., Xu, Z., Lin, Z., Chen, F., Dong, Z.
Publication Year: 2024
Journal: Acta Biomaterialia
Citations: 2

 

Dr. Ying Zhang | Respiratory Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Ying Zhang | Respiratory Infectious Diseases | Best Researcher Award

 The First Hospital of Jilin University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Zhang Ying began her academic journey in 2002 when she enrolled in the seven-year clinical medicine program at Jilin University. Upon graduating in 2009, she gained a solid foundation in clinical practice and medical sciences. Driven by a passion for research excellence, she continued her academic pursuits and obtained her Doctor of Science degree in 2020, marking the culmination of her academic dedication and commitment to advancing the field of pediatric respiratory medicine. This achievement reflects her expertise in both clinical medicine and scientific research.

🩺PROFESSIONAL ENDEAVORS

  • Current Position: Consultant Physician in the Department of Pediatric Respiratory Medicine at the First Hospital of Jilin University.
  • Clinical Expertise: Zhang specializes in pediatric respiratory diseases, offering both clinical care and research leadership. She is focused on diagnosing and treating complex respiratory infections and diseases in children, leveraging her extensive knowledge and expertise to improve patient outcomes.
  • Research Leadership: In addition to her clinical work, Zhang has pioneered research that bridges the gap between clinical care and molecular medicine, particularly in respiratory infectious diseases.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON RESPIRATORY INFECTIOUS DISEASES

Zhang Ying’s research is dedicated to advancing the understanding and treatment of respiratory infectious diseases, with a strong emphasis on precision medicine and molecular diagnostics:

  1. Extracellular Vesicles in Respiratory Diseases: Zhang’s research explores the role of extracellular vesicles in diseases like chronic obstructive pulmonary disease (COPD), offering insights into potential biomarkers and therapeutic targets.
  2. Pathogen Identification and Drug Resistance: She has developed innovative methods for rapid identification and drug resistance screening of respiratory pathogens using single-cell Raman spectroscopy, a cutting-edge approach in molecular diagnostics.

🌍 IMPACT AND INFLUENCE

Zhang Ying has made a profound impact in the field of infectious diseases, particularly in pediatric respiratory care. Through her research, she has enhanced the understanding of the molecular mechanisms behind respiratory infections, providing valuable insights into precision medicine and personalized therapies. Her work has influenced both clinical practice and molecular diagnostics, offering innovative solutions to improve outcomes for children with complex respiratory conditions.

📚 ACADEMIC CITATIONS

  • A new frontier in precision medicine: Exploring the role of extracellular vesicles in COPD – Biomedicine & Pharmacotherapy, 2024.
  • Rapid identification and drug resistance screening of respiratory pathogens based on single-cell Raman spectroscopy – Front. Microbiol., 2023.
  • Aerosolization inhalation of non-typeable Haemophilus influenzae outer membrane vesicles contributing to neutrophilic asthma – Front. Microbiol., 2023.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Zhang Ying’s research has paved the way for major advancements in respiratory infectious diseases, particularly for pediatric patients. Her work on extracellular vesicles, exosomes, and molecular diagnostics has the potential to revolutionize how respiratory infections are diagnosed and treated. Her legacy will continue through her contributions to personalized medicine, improving the early detection and targeted treatment of respiratory diseases in children.

📑 NOTABLE PUBLICATIONS 

“A new frontier in precision medicine: Exploring the role of extracellular vesicles in chronic obstructive pulmonary disease”

Authors: Gou, Z., Yang, H., Wang, R., Liu, Z., Zhang, Y.

Journal: Biomedicine and Pharmacotherapy

Year: 2024

Citations: 2

“Rapid identification and drug resistance screening of respiratory pathogens based on single-cell Raman spectroscopy”

Authors: Liu, Z., Xue, Y., Yang, C., Li, B., Zhang, Y.

Journal: Frontiers in Microbiology

Year: 2023

Citations: 6

“Aerosolization inhalation of non-typeable Haemophilus influenzae outer membrane vesicles contributing to neutrophilic asthma”

Authors: Zhang, Y., Wang, H., Zhang, Y., Zhao, P., Li, Y.

Journal: Frontiers in Microbiology

Year: 2023

Citations: 5

“Exosomes in HBV infection”

Authors: Liu, Z., Li, Y., Wang, Y., Bai, X., Zhang, Y.

Journal: Clinica Chimica Acta

Year: 2023

Citations: 17

“Engineering Coinage Metal Nanoclusters for Electroluminescent Light-Emitting Diodes”

Authors: Li, T., Wang, Z., Zhang, Y., Wu, Z.

Journal: Nanomaterials

Year: 2022

Citations: 4